La presidenta de la Asociación Española de Laboratorios de Medicamentos Huérfanos y Ultrahuérfanos (AELMHU), Beatriz Perales, ha participado este jueves en la tercera edición de Únicas Talks, una jornada organizada por el Hospital Sant Joan ... Leer más
May 29, 2026
AELMHU at SEDISA's 'Spain Global Rare Diseases Summit'
Marian Corral, director of the Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU), participated this Friday in the “Spain Global Rare Diseases Summit,” organized by the Spanish Society of Executives ... Read more
May 27, 2026
AELMHU has appointed a new Board of Directors for the next two years
The General Assembly of the Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU), comprising its 29 member companies, elected the Association’s new Board of Directors on Wednesday for the term ... Read more
May 19, 2026
Report on Clinical Trials for Rare Diseases in Spain 2025
The Spanish Association of Laboratories for Orphan and Ultra-Orphan Drugs (AELMHU) has published the “Report on Clinical Trials for Rare Diseases in Spain 2025,” which analyzes the most relevant data on authorized clinical trials ... Read more
May 7, 2026
Advanced therapies for rare diseases require a comprehensive approach that goes beyond the healthcare sector
The Spanish Association of Laboratories for Orphan and Ultra-Orphan Drugs (AELMHU) has highlighted the need for a comprehensive approach to advanced therapies for rare diseases during its 4th ... Read more
May 5, 2026
Unmet medical needs in rare diseases
Marian Corral, director of the Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU), participated on Monday in the discussion forum “Unmet Medical Needs: Perspectives and Consensus in Light of the New ... Read more
